Beam Therapeutics
Our vision is to provide life-long cures for patients suffering from serious diseases.
597 employees · est. 2017 · Cambridge, United States
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based technology
23 employees · est. 2016 · Cambridge, United States
Modalis Therapeutics is the older company (2017 vs 2016); Beam Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Beam Therapeutics | Modalis Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Cambridge, United States |
| Employees | ||
| Employees | 597 larger | 23 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $1.66B | $934.72M |
| Funding Rounds | ||
| Funding Rounds | 7 | 7 |
| Services | ||
| Services | Base Editing Technology, Precision Genetic Medicines, Clinical Trials Services, Innovation in Gene-based Editing, Development of Delivery Modalities | CRISPR-GNDM technology, epigenome editing, gene therapy development, genome editing solutions, therapeutic pipeline development |
| Target Customers | ||
| Target Customers | Patients with Genetic Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies, Investors in Biotech Sector | patients with genetic disorders, pharmaceutical companies, healthcare providers, biomedical researchers |
| Taxonomy | ||
| Taxonomy | CRISPR Base Editing, Precision Genetic Medicines, Gene Therapy, Genetic Diseases, Rare Diseases, Hematology, Lipid Nanoparticles, Vector Production, In Vivo Editing, Ex Vivo Editing, MRNA Production, Viral Delivery, Nanoparticles Formulation, Protein Sciences, Cell Therapy | Biotech Company, Genetic Medicines, CRISPR Technology, Epigenetic Gene Modulation, Precision Medicine, Orphan Genetic Diseases, Proprietary Technology, University Of Tokyo, Innovation, R&D Facilities, Tokyo Mothers 4883, Therapeutics Development, Intellectual Property, Protein Engineering, Transformative Therapeutics |
| Website | ||
| Website | beamtx.com | modalistx.com |
About Beam Therapeutics
Beam Therapeutics, founded in 2017, is at the forefront of the biotechnology industry with its cutting-edge use of CRISPR base editing technology. Headquartered in the United States, this innovative company focuses on developing a broad portfolio of genetic medicines that promise lifelong cures for...
About Modalis Therapeutics
Modalis Therapeutics, an emerging biotech company founded in 2016, is pioneering the development of therapeutics using CRISPR-based technology. The company's core offering revolves around its proprietary CRISPR-GNDM technology, which allows for precise gene expression and histone modification withou...
We will tell you when either one moves
BounceWatch watches Beam Therapeutics and Modalis Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Beam Therapeutics and Modalis Therapeutics — by email.
Frequently Asked Questions
Compare Beam Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Beam Therapeutics on 15 Jun 2026, and Modalis Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.